Completed
An international commission has been convened by the U.S. National Academy of Medicine, the U.S. National Academy of Sciences, and the U.K.’s Royal Society, with the participation of academies of sciences and medicine from around the world. The commission will develop a framework for scientists, clinicians, and regulatory authorities to consider when assessing potential clinical applications of human germline genome editing, should society conclude that heritable human genome editing applications are acceptable.
Events
Meetings
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People